WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Low AGE diet
Procedure: Research blood draw

First Posted Date: 2022-03-03

Last Posted Date: 2024-03-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT05265715

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid

Phase 2

Terminated

Conditions: Mucous Membrane Pemphigoid
Cicatrizing Conjunctivitis

Interventions: Drug: Methotrexate
Drug: Baricitinib 2 MG [Olumiant]
Drug: Azathioprine
Drug: Mycophenolate

First Posted Date: 2022-03-02

Last Posted Date: 2023-11-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT05263505

Locations: 🇺🇸
Barnes Jewish Hospital / Washington University in St. Louis, Saint Louis, Missouri, United States

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Phase 2

Withdrawn

Conditions: Brain Metastases
Triple Negative Breast Cancer

Interventions: Drug: Pembrolizumab
Drug: Liposomal Irinotecan

First Posted Date: 2022-02-24

Last Posted Date: 2023-07-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05255666

Samaki Salama: Small-scale Fisheries for Healthy Nutrition and Ecosystems

Not Applicable

Conditions: Malnutrition, Child
Growth; Stunting, Nutritional

Interventions: Behavioral: Social marketing
Behavioral: social marketing + gear modification

First Posted Date: 2022-02-24

Last Posted Date: 2022-02-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1200

Registration Number: NCT05254444

Locations: 🇰🇪
Pwani University, Kilifi, Kenya

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Phase 2

Terminated

Conditions: Ampullary Cancer
Pancreas Neuroendocrine Tumor
Pancreatitis
Pancreatic Cancer
Distal Extrahepatic Cholangiocarcinoma
Pancreas Cancer
Duodenal Cancer

Interventions: Drug: Placebo
Drug: Pantoprazole

First Posted Date: 2022-02-22

Last Posted Date: 2024-07-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT05251233

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Evolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain Development

Not Applicable

Active, not recruiting

Conditions: Stunting
Growth Disorders
Maternal Nutritional Disorders Affecting Fetus or Newborn
Malnutrition, Fetal
Development; Delayed, Malnutrition
Nutrition Disorder, Fetal

Interventions: Other: Evolutionary Nutrition Package

First Posted Date: 2022-02-16

Last Posted Date: 2024-10-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 200

Registration Number: NCT05242224

Locations: 🇪🇨
Universidad San Francisco de Quito, Quito, Pichincha, Ecuador

Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial

Phase 3

Completed

Conditions: Postoperative Depression

Interventions: Drug: Normal saline
Drug: Ketamine

First Posted Date: 2022-02-10

Last Posted Date: 2024-04-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 32

Registration Number: NCT05233566

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Community-based CBT and T2D in Latino Population

Not Applicable

Terminated

Conditions: Type 2 Diabetes
Mental Health Issue
Quality of Life
Weight Loss

Interventions: Behavioral: CBT-based lifestyle intervention

First Posted Date: 2022-02-03

Last Posted Date: 2024-06-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 11

Registration Number: NCT05222373

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia

Phase 2

Withdrawn

Conditions: Olfactory Disorder
Parosmia
COVID-19

Interventions: Drug: Placebo
Drug: Fluvoxamine

First Posted Date: 2022-01-31

Last Posted Date: 2022-03-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05216614

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

RYSE Family-based Behavioral Treatment for Childhood Obesity

Not Applicable

Active, not recruiting

Conditions: Obesity, Childhood

Interventions: Behavioral: family-based behavioral treatment (FBT)

First Posted Date: 2022-01-27

Last Posted Date: 2024-07-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 108

Registration Number: NCT05212155

Locations: 🇺🇸
Freeman Health Pediatrics Clinics, Joplin, Missouri, United States
🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy